METHODS OF MODULATING GASTROINTESTINAL METABOLITES
Applicants:
- Novozymes (Denmark) [NORA names: Novonesis; Private Research; Denmark; Europe, EU; Nordic; OECD]
- DSM (Netherlands) [NORA names: Netherlands; Europe, EU; OECD]
Abstract
The present disclosure relates to methods of feeding animals by providing feed additives that modulate the gut microbiome to improve the health, nutrition, and growth performance. The present disclosure further relates to methods of modulating metabolites present in the gastrointestinal tract of an animal. Such modulation includes, for example, modulating the level said metabolites.
Patent Family Records (5)
METHODS OF MODULATING GASTROINTESTINAL METABOLITES
DSM (Netherlands), DSM IP Assets BV, Novozymes (Denmark), Novozymes AS CLAYPOOL JOSHUA, SCHYNS GHISLAIN
2024, AU-2021360228-A9
METHODS OF MODULATING GASTROINTESTINAL METABOLITES
DSM (Netherlands), DSM IP Assets BV, Novozymes (Denmark), Novozymes AS CLAYPOOL JOSHUA, SCHYNS GHISLAIN
2023, US-20230405091-A1
METHODS OF MODULATING GASTROINTESTINAL METABOLITES
DSM (Netherlands), DSM IP Assets BV, Novozymes (Denmark), Novozymes AS CLAYPOOL JOSHUA, SCHYNS GHISLAIN
2023, EP-4228424-A1
METHODS OF MODULATING GASTROINTESTINAL METABOLITES
DSM (Netherlands), DSM IP Assets BV, Novozymes (Denmark), Novozymes AS CLAYPOOL JOSHUA, SCHYNS GHISLAIN
2023, AU-2021360228-A1
METHODS OF MODULATING GASTROINTESTINAL METABOLITES
DSM (Netherlands), DSM IP ASSETS BV, NOVOZYMES AS, Novozymes (Denmark) CLAYPOOL JOSHUA, SCHYNS GHISLAIN
2022, WO-2022079238-A1